• 1. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
• 2. An insight into the origin of room-temperature ferromagnetism in SnO2 and Mn-doped SnO2 quantum dots: an experimental and DFT approach?
  Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514
• 3. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 4. An air-stable organometallic polymer containing titanafluorene moieties obtained by the Sonogashira–Hagihara cross-coupling polycondensation?
  Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043
• 5. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Imidazopyridines Imidazopyridines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Imidazopyridines

Introduction to 7-Bromo-3H-imidazo[4,5-b]pyridine (CAS No: 1207174-85-3)

7-Bromo-3H-imidazo[4,5-b]pyridine, identified by its Chemical Abstracts Service (CAS) number 1207174-85-3, is a heterocyclic compound that has garnered significant attention in the field of pharmaceutical and chemical research. This compound belongs to the imidazopyridine class, a structural motif known for its broad biological activity and utility in drug discovery. The presence of a bromine substituent at the 7-position enhances its reactivity, making it a valuable intermediate in synthetic chemistry and medicinal chemistry applications.

The imidazopyridine scaffold is a privileged structure in medicinal chemistry, exhibiting diverse pharmacological properties across multiple therapeutic areas. 7-Bromo-3H-imidazo[4,5-b]pyridine has been explored in various research endeavors due to its potential as a building block for the development of novel bioactive molecules. Its unique electronic and steric properties allow for facile functionalization, enabling the synthesis of complex derivatives with tailored biological activities.

In recent years, 7-Bromo-3H-imidazo[4,5-b]pyridine has been utilized in the synthesis of small-molecule inhibitors targeting critical biological pathways. For instance, studies have demonstrated its role in developing compounds that interact with kinases and other enzyme targets involved in cancer metabolism. The bromine atom at the 7-position serves as a handle for further chemical modifications, such as Suzuki-Miyaura cross-coupling reactions, which are widely employed to construct biaryl structures prevalent in many drugs.

One notable application of 7-Bromo-3H-imidazo[4,5-b]pyridine is in the development of antiviral agents. The imidazopyridine core has been shown to exhibit inhibitory effects against certain viral proteases and polymerases. Researchers have leveraged the reactivity of this compound to design derivatives that disrupt viral replication cycles, offering promising leads for future antiviral therapies. The brominated derivative is particularly useful in these contexts due to its compatibility with transition-metal-catalyzed reactions, which facilitate the introduction of additional functional groups essential for potent biological activity.

The pharmaceutical industry has also explored 7-Bromo-3H-imidazo[4,5-b]pyridine as a precursor for central nervous system (CNS) drugs. Imidazopyridines are known to modulate neurotransmitter systems, making them attractive candidates for treating neurological disorders. By incorporating this scaffold into drug candidates, researchers aim to develop compounds that enhance cognitive function or alleviate symptoms associated with conditions such as Alzheimer's disease or schizophrenia. The bromine substituent allows for further derivatization to optimize pharmacokinetic properties and target specificity.

From a synthetic chemistry perspective, 7-Bromo-3H-imidazo[4,5-b]pyridine serves as a versatile intermediate in multi-step syntheses. Its ability to undergo various transformations under mild conditions makes it an indispensable tool for medicinal chemists seeking to explore novel molecular architectures. The compound's stability under different reaction conditions further enhances its utility in complex synthetic routes.

The growing interest in 7-Bromo-3H-imidazo[4,5-b]pyridine is reflected in the increasing number of patents and scientific publications reporting its use in drug discovery programs. Companies and academic institutions alike are investing resources into exploring its potential applications across diverse therapeutic areas. As research continues to uncover new biological targets and mechanisms, the demand for high-quality intermediates like 7-Bromo-3H-imidazo[4,5-b]pyridine is expected to rise.

In conclusion, 7-Bromo-3H-imidazo[4,5-b]pyridine (CAS No: 1207174-85-3) represents a significant advancement in pharmaceutical chemistry. Its unique structural features and reactivity make it an invaluable asset for researchers developing novel therapeutics. As scientific understanding evolves and new methodologies emerge, this compound will undoubtedly continue to play a pivotal role in shaping the future of drug discovery and development.

• 1000340-32-8(4-BROMO-PYRROLO[2,3-F]-7-AZAINDOLE)
• 42869-47-6(6-Bromo-2-methyl-3H-imidazo[4,5-b]pyridine)
• 1052271-60-9(8-bromoimidazo[1,5-a]pyridine)
• 1401687-52-2(7-bromo-2-chloro-1h-imidazo[4,5-b]pyridine)
• 52333-42-3(7-Bromopyrido[2,3-b]pyrazine)
• 438190-89-7(6-bromo-2-chloro-3H-imidazo4,5-bpyridine)
• 28279-49-4(6-bromo-3H-imidazo[4,5-b]pyridine)
• 1250115-39-9(6-bromo-1H-imidazo4,5-bpyridin-2-amine)
• 56015-31-7(7-bromo-5H-pyrrolo[2,3-b]pyrazine)
• 90993-26-3(7-bromo-3H-imidazo[4,5-c]pyridine)